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ABSTRACT
RNA levels in a cell are determined by the relative rates of RNA synthesis and decay. State-of-the-art transcriptional analyses
only employ total cellular RNA. Therefore, changes in RNA levels cannot be attributed to RNA synthesis or decay, and temporal
resolution is poor. Recently, it was reported that newly transcribed RNA can be biosynthetically labeled for 1–2 h using
thiolated nucleosides, purified from total cellular RNA and subjected to microarray analysis. However, in order to study
signaling events at molecular level, analysis of changes occurring within minutes is required. We developed an improved
approach to separate total cellular RNA into newly transcribed and preexisting RNA following 10–15 min of metabolic labeling.
Employing new computational tools for array normalization and half-life determination we simultaneously study short-term
RNA synthesis and decay as well as their impact on cellular transcript levels. As an example we studied the response of
fibroblasts to type I and II interferons (IFN). Analysis of RNA transcribed within 15–30 min at different times during the first
three hours of interferon-receptor activation resulted in a >10-fold increase in microarray sensitivity and provided a
comprehensive profile of the kinetics of IFN-mediated changes in gene expression. We identify a previously undisclosed highly
connected network of short-lived transcripts selectively down-regulated by IFNg in between 30 and 60 min after IFN treatment
showing strong associations with cell cycle and apoptosis, indicating novel mechanisms by which IFNg affects these pathways.
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INTRODUCTION
Multiple regulatory processes govern the flow of genetic
information from DNA to protein. Stimulated cells alter
transcription rates of individual genes within minutes (Liu
et al. 2007). Characteristic and differential mRNA turnover
rates either contribute to rapid changes in cellular gene
expression profiles or rigidly maintain constant transcript
levels. Thus, mRNA levels of genes at a given time are the
result of an intensively regulated balance between de novo
transcription and mRNA decay (Guhaniyogi and Brewer
2001; Fan et al. 2002; Jing et al. 2005).
Standard microarray analyses on total cellular RNA
(total RNA) provide a measure of mRNA abundance but
cannot discriminate whether changes are due to alterations
in RNA synthesis or decay. Numerous attempts have been
undertaken to circumvent this problem. De novo transcrip-
tion and its contribution to steady-state mRNA levels were
determined using nuclear transcription run-on assays
(Hirayoshi and Lis 1999; Fan et al. 2002; Garcia-Martinez
et al. 2004). However, these assays are not readily com-
patible with standard microarray formats. Decay rates have
been determined by blocking transcription, e.g., using
actinomycin-D (act-D), assuming mRNA decay to continue
at its normal rate (Frevel et al. 2003; Yang et al. 2003;
Bernstein et al. 2004; Raghavan and Bohjanen 2004). How-
ever, this method is inherently cell invasive and cannot be
combined with assays used to measure de novo transcription.
Low temporal resolution for regulatory changes is
another major limitation of standard expression profiling
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using total RNA. This is particularly true for mammalian
cells due to the relatively long half-life of their mRNAs.
While the median mRNA half-life (t½m) in prokaryotic cells
is in the range of 20–30 min (Bernstein et al. 2002), t½m in
human cells was reported to be 600 min (Yang et al. 2003).
Hence, even hours after a >100-fold transient down-
regulation in transcription rate, this is hardly detectable
in total RNA without concordant changes in mRNA decay.
In addition, for the majority of transcripts a 10-fold up-
regulation in transcription rate requires >2 h to result in a
twofold increase in abundance. Therefore, primary changes
cannot be differentiated from subsequent events by assays
measuring transcript abundance only.
It has been known for 30 years that thiol-group con-
taining nucleosides such as 4-thiouridine (4sU) can be
introduced into nucleoside salvage pathways in eukaryotic
cells and allow nondisruptive metabolic labeling of newly
transcribed RNA (Melvin et al. 1978). These can be used to
separate newly transcribed RNA from total RNA using
mercury affinity chromatography (Melvin et al. 1978;
Woodford et al. 1988; Ussuf et al. 1995; Kenzelmann et al.
2007) or thiol-specific biotinylation and subsequent puri-
fication on streptavidin-coated magnetic beads (Cleary
et al. 2005) as eukaryotic mRNAs normally do not contain
thiol-groups. Here we report on an integrated, improved
approach in which the advantages of direct incorporation
of 4sU are combined with thiol-specific biotinylation and
simple magnetic separation of total RNA into newly tran-
scribed RNA and preexisting unlabeled RNA. This allows
microarray analysis on all three obtained RNA subsets in
parallel. Thus, for the first time, changes in RNA synthesis
and decay as well as their impact on cellular transcript
levels can be analyzed in a single experimental setting.
Theoretically, short-term biosynthetic labeling for 15–30
min at different times during cytokine treatment should
allow differentiation of the temporal order and kinetics of
changes in gene expression at molecular level. We demon-
strate this by analyzing the cellular response to type I and II
interferons (IFN). IFNs are an intensively studied family of
multifunctional cytokines known to dramatically alter
transcription rates of hundreds of transcripts (for review,
see Platanias 2005). They play an essential role in innate
immunity in response to viral, bacterial, and parasitic path-
ogens (Stetson and Medzhitov 2006). In addition, they
exert important anti-proliferative as well as immune mod-
ulatory properties (Boxel-Dezaire et al. 2006).
RESULTS
Separation of total cellular RNA into newly
transcribed and preexisting RNA
Metabolic labeling of newly transcribed RNA with 4sU has
minimal adverse effects on gene expression, RNA decay,
protein stability, and cell viability (Melvin et al. 1978;
Woodford et al. 1988; Ussuf et al. 1995; Kenzelmann et al.
2007). We compared the global transcriptional profile of
three biological replicates of NIH-3T3 cells exposed to 200
mM 4sU for one hour with nontreated cells. No significant
differential expression (more than twofold and P < 0.05)
attributable to 4sU treatment was detected (see Supple-
mental Fig. 1). We analyzed 4sU incorporation into newly
transcribed RNA by culturing various cell types in the
presence of 100 mM to 5 mM 4sU for one hour. Following
isolation of total cellular RNA and thiol-specific biotinylation,
FIGURE 1. Detection and quantification of 4sU incorporation into
RNA. 4sU is quantitatively incorporated into newly transcribed RNA
by a broad range of cell lines of human and murine origin. Dot blot
analyses of thiol-mediated biotinylation of RNA derived from (A)
murine NIH-3T3 fibroblasts, (B) SVEC 4-10 endothelial cells, and (C)
DG75 human B-cells exposed to 100 mM to 5 mM 4sU for 1 h are
shown as examples. Nonlabeled RNA samples (0) were used as
controls. All RNA samples were spotted in 10-fold dilutions (top to
bottom: 1 mg down to 1 ng). A 59-biotinylated DNA oligo of 81 nt
(PC) was used in 10-fold dilutions (100 ng down to 0.1 ng) to
quantify biotin-labeling. (D) Kinetics of 4sU incorporation into
cellular RNA were analyzed. NIH-3T3 cells were cultured in the
presence of 1 mM 4sU for 0, 15, 30, 45, 60, 90, and 120 min. Dot blot
analyses of biotinylated RNA samples are shown as for A–C. (E)
Newly transcribed RNA was labeled in NIH-3T3 cells using 500 mM
4sU for 0, 5, 10, 15, 20, and 30 min. Following isolation of total
cellular RNA and thiol-specific biotinylation, newly transcribed RNA
was purified from 100 mg biotinylated total RNA. Half of the purified
RNA was separated on an ethidium bromide-stained agarose gel
under nondenaturating conditions.
Do¨lken et al.
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4sU-labeled RNA was specifically detected and quantified
by dot blot assay. We found 4sU to be efficiently incorpo-
rated into RNA by a broad range of cell types of human and
murine origin including fibroblasts, endothelial cells, and
B-cells (Fig. 1A–C) as well as dendritic cells, macrophages,
and T-cells (data not shown). Labeled RNA was detectable
by dot blot analysis after 15 min of labeling (Fig. 1D).
In cells expressing Toxoplasma gondii uracil-phosphor-
ibosyltransferase (UPRT) newly transcribed RNA can be
metabolically labeled using 4-thiouracil (4tU) (Cleary et al.
2005). In this report newly transcribed RNA was isolated by
thiol-specific biotinylation followed by affinity purification
on streptavidin-coated magnetic beads. We adapted this
approach to 4sU labeling, which does not require UPRT
expression. We established an improved, column-based
protocol for magnetic separation of total RNA into newly
transcribed RNA and preexisting RNA (for details, see
Materials and Methods). Employing this approach, high-
molecular-weight newly transcribed RNA could be detected
by agarose gel electrophoresis after as little as 10 min of
labeling (Fig. 1E). After one hour of labeling newly
transcribed RNA accounted for 3%–6% of total RNA
depending on the cell type under study (data not shown).
The efficiency of separation was validated by combining
4sU and 3H-cytidine to label newly transcribed RNA for 15,
30, and 60 min. After thiol-specific biotinylation up to 90%
of 3H-cytidine-labeled RNA copurified with the newly
transcribed RNA fraction (see Supplemental Fig. 2A–D).
When 3H-labeled, unbiotinylated RNA was subjected to
this separation procedure, the first two of a total of six
washing steps already contained the bulk of labeled RNA,
indicating preparative recovery of both newly transcribed
TABLE 1. Comparison of RNA ratios and half-lives obtained by RNA labeling and by blocking transcription using act-D
Gene title
Newly transcribed/total RNA 1 h act-D 2 h act-D
Ratio (%) t1/2 (h) Ratio (%) t1/2 (h) Ratio (%) t1/2 (h)
Dual specificity phosphatase 5 94.4 0.2 11.5 0.3 2.2 0.4
Dual specificity phosphatase 6 93.5 0.2 8.0 0.3 3.0 0.4
Jun oncogene 74.6 0.5 22.4 0.5 6.6 0.5
Fos oncogene 54.1 0.8 83.8 3.9 13.2 0.7
Suppressor of cytokine signaling 3 67.6 0.6 5.2 0.2 5.9 0.5
Suppressor of cytokine signaling 5 55.4 0.8 37.0 0.7 35.2 1.3
E2F transcription factor 3 38.8 1.3 56.1 1.2 12.4 0.7
E2F transcription factor 7 36.5 1.4 59.6 1.3 21.5 0.9
Cyclin T2 25.0 2.2 48.4 1.0 23.4 1.0
Cyclin L2 24.5 2.3 113.9 NC 83.3 7.6
Lamin B1 8.5 7.2 95.6 15.3 60.1 2.7
Myosin IB 8.4 7.2 105.0 NC 76.4 5.2
Proteasome (prosome, macropain)
subunit, beta type 6
6.2 10.0 107.9 NC 84.3 8.1
Proteasome (prosome, macropain)
subunit, beta type 4
6.1 10.1 115.5 NC 78.9 5.8
Proteasome (prosome, macropain)
subunit, alpha type 5
5.9 10.5 81.4 3.4 67.5 3.5
NADH dehydrogenase (ubiquinone)
Fe-S protein 1
4.7 13.1 96.2 18.0 74.6 4.7
NADH dehydrogenase (ubiquinone)
Fe-S protein 8
4.4 14.0 77.3 2.7 87.1 10.0
NADH dehydrogenase (ubiquinone)
Fe-S protein 3
4.2 14.7 99.0 67.1 77.0 5.3
ATP synthase, H+ transporting,
mitochondrial F1 complex,
epsilon subunit
2.0 30.8 84.1 4.0 81.6 6.8
ATP synthase, H+ transporting,
mitochondrial F0 complex, subunit d
1.9 33.5 95.1 13.9 82.3 7.1
Catalase 1.2 51.7 92.0 8.3 89.2 12.1
Procollagen, type IV, alpha 5 1.2 53.2 72.3 2.1 83.5 7.7
In NIH-3T3 cells newly transcribed RNA was labeled for 60 min using 200 mM 4sU. Total cellular RNA was isolated and newly transcribed
RNAwas purified. In a second experiment carried out in parallel, RNA synthesis was blocked for 1 and 2 h using act-D. Microarray analysis was
performed on three replicates of each RNA subset. Array data for newly transcribed RNA and total RNA were normalized by adjusting the
median newly transcribed RNA/total RNA ratio to the ratio calculated for the median mRNA half-life we determined for NIH-3T3 cells (295
min). The same was done for the act-D-based ratios and half-lives were calculated as described (Yang et al. 2003). Examples of short-, medium-,
and long-lived genes with similar function are shown. For ratios >100% no half-life can be calculated (NC).
High-resolution gene expression profiling
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FIGURE 2. (Legend on next page)
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Fig. 2 live 4/C
RNA and preexisting RNA from total RNA. Thus, both
RNA subsets, present in the same isolated RNA sample, can
be separated with high purity.
Development of an integrative approach to
simultaneously analyze RNA synthesis and decay
For every transcript total RNA levels are constantly sub-
jected to changes in RNA synthesis and decay. So far it was
not possible to analyze both parameters in a systemic
approach in a single experimental setting. The standard
method used to study RNA decay is to block transcription,
e.g., using act-D (Frevel et al. 2003; Yang et al. 2003).
However, this approach has a number of limitations. First,
blocking transcription provokes a cellular stress response.
Some important mechanisms that control mRNA stability,
e.g., miRNA-mediated control of gene expression (Jing
et al. 2005), are released in cells subjected to stress
(Bhattacharyya et al. 2006). In addition, some transcripts
have been shown to be rapidly stabilized following act-D
treatment (Shyu et al. 1989). Second, for the vast majority
of mammalian mRNAs, decay rates determined by blocking
transcription are based on very small differences in tran-
script levels. Only in the case of very short-lived transcripts
(t1/2 < 2 h), RNA levels decrease by >50% upon 2 h of
transcriptional blockage. Thus, act-D-based measurements
of RNA decay are inherently imprecise for the majority of
cellular transcripts.
We developed a novel approach to simultaneously study
RNA synthesis and decay for which blocking transcription
is not required. Under steady-state conditions, RNA syn-
thesis compensates for RNA decay to maintain stable
transcript levels. Therefore, de novo synthesis rates are
much higher for short-lived transcripts than for long-lived
transcripts. In murine fibroblasts, we found newly tran-
scribed RNA/total RNA ratios to vary from 1% to 2% for
long-lived to >95% for very short-lived transcripts (for
examples, see Table 1). Based on the newly transcribed
RNA/total RNA ratios (R) and the duration of labeling (tL)
precise data on mRNA half-life (t1/2) can be calculated
according to the following equation: t1/2 = tL 3 ln(2) /
ln(1  R) (for details, see Supplemental Methods). Thus,
assuming steady-state conditions mRNA synthesis and
decay rates can be determined by simply analyzing newly
transcribed RNA and total RNA derived from the same
RNA sample.
We applied this approach to determine mRNA half-lives
for murine fibroblasts. Newly transcribed RNA was labeled
in NIH-3T3 cells for 60 and 30 min. After isolation of total
cellular RNA newly transcribed RNA was separated from it.
Three replicates of both total RNA and newly transcribed
RNA were subjected to microarray analysis. Half-life mea-
surements based on newly transcribed RNA/total RNA
ratios resulted in precise and reproducible data indepen-
dent of mRNA half-life ranging from <20 min to >2 d
(Fig. 2A,B).
If steady-state conditions are not given there is no
equilibrium in between RNA synthesis and decay. There-
fore, only RNA synthesis is analyzed using newly tran-
scribed RNA while RNA decay is determined by comparing
preexisting RNA obtained after the application of a
stimulus, e.g., a cytokine, with total RNA levels prior to it
[ t1/2 = tL 3 ln(2) / ln(P), with P = preexisting RNA/total
RNA]. Thereby, the polar effects of act-D treatment on
RNA decay are avoided as, instead of blocking RNA
synthesis, newly transcribed RNA is physically separated
from total RNA.
For act-D-based determination of RNA decay rates, array
data from RNA samples obtained after blocking transcrip-
tion have to be adjusted to data from samples prior to it.
This kind of normalization is usually based on the mRNA
half-life of a housekeeping gene (e.g., b-actin) indepen-
dently determined in a separate experiment (Yang et al.
2003). It is a crucial step for comparing data from
independent experiments and is also required when RNA
half-lives are determined based on newly transcribed
RNA/total RNA or preexisting RNA/total RNA ratios. We
developed a novel approach to solve this task by statistical
means based on the separation of total RNA into newly
transcribed and preexisting RNA. For all probe sets the sum
FIGURE 2. (A,B) Analysis of mRNA half-lives determined based on newly transcribed RNA/total RNA ratios. Newly transcribed RNA was
labeled in NIH-3T3 cells for 60 or 30 min. Total cellular RNA was separated into newly transcribed RNA and unlabeled preexisting RNA. For each
experiment three biological replicates of each RNA subset were subjected to microarray analysis. For each condition half-lives were determined
based on newly transcribed RNA/total RNA ratios obtained from >13,000 probe sets. Scatterplots comparing half-lives (in minutes) obtained by
60 min of labeling in separated experiments (A) and by 30 min of labeling within a single experiment (B) are shown. Red lines indicate deviations
from the regression line (green) by twofold in either direction. (C) Normalization of total RNA, newly transcribed RNA, and preexisting RNA
microarray data using linear regression analysis. Preexisting RNA/total RNA ratios were plotted against newly transcribed RNA/total RNA ratios.
As total RNA is separated into newly transcribed RNA and preexisting RNA, the sum of the two ratios should equal 100% for every transcript.
Therefore, a linear correlation exists between the two ratios and linear regression analysis (green line) can be used to determine the parameters
required for correct data normalization. Thereby, a median mRNA half-life of 295 min was determined for NIH-3T3 cells. (D–F) Comparison of
mRNA half-lives obtained by RNA labeling and actinomycin-D treatment (act-D). In parallel to the RNA labeling experiments, RNA synthesis
was blocked in NIH-3T3 cells for 1 and 2 h using act-D. Microarray analyses were performed on three replicates of each RNA subset. (D) Half-
lives determined by 2 h act-D treatment and 60 min of labeling correlated reasonably well. (E) Half-lives (in minutes) determined by blocking
transcription for 1 and 2 h using act-D only correlated well for very short-lived transcripts (t1/2 < 2 h) but poor for the remaining transcripts. (F)
Half-lives (in minutes) obtained by 15 and 30 min of labeling within a single experiment were compared to identify potential effects caused by
4sU labeling. Significant differences were only observed for very short-lived transcripts (t1/2 < 50 min).
High-resolution gene expression profiling
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of the ratios of newly transcribed RNA/total RNA and
preexisting RNA/total RNA must equal 100% as total RNA
is separated into newly transcribed RNA and preexisting
RNA. Due to the linear relation between the two ratios,
normalization parameters simply result from linear regres-
sion analysis. Thus, normalization is based on thousands of
probe sets and does not require data from separate experi-
ments (for details, see Supplemental Methods). To dem-
onstrate this, we labeled RNA in NIH-3T3 cells for one
hour and separated newly transcribed RNA from preexist-
ing RNA. Three replicates of each RNA subset were
subjected to microarray analysis. Normalization parameters
were determined based on linear regression analysis on
array data of >13,000 probe sets with ‘‘present’’ calls in all
arrays (Fig. 2C). mRNA half-lives were obtained using both
the newly transcribed RNA/total RNA as well as preexisting
RNA/total RNA ratios. The median mRNA half-life (t1/2m)
in NIH-3T3 fibroblasts was 295 min. To our knowledge a
median mRNA half-life in cells of murine origin has not
been described. Once the median mRNA half-life of a given
cell type has been determined, array normalization can be
achieved by normalizing the median newly transcribed
RNA/total RNA ratio to the corresponding ratio predicted
for the median mRNA half-life.
In order to validate our new approach we compared
mRNA half-lives obtained from NIH-3T3 fibroblasts based
on newly transcribed RNA/total RNA ratios with data ob-
tained by the standardmethod, i.e., by blocking transcription
for 1 and 2 h using act-D. Data obtained by 2 h act-D and
60 min of labeling correlated reasonably well (Fig. 2D). In
contrast, decay rates obtained by blocking transcription
(1 h versus 2 h act-D) only correlated well for transcripts
with a half-life of <2 h (Fig. 2E). In order to analyze the
effect of time on our new method and show that precise
data on mRNA half-life can already be determined after
very short labeling, we compared half-lives obtained by 15
and 30 min of labeling. We found half-lives to correlate
extremely well (Fig. 2F).
Interestingly, there is deviation from the linear correla-
tion for small values (t1/2 < 60 min, <5% of all transcripts)
and this was also seen when comparing half-lives obtained
by 15 and 60 as well as 30 and 60 min of labeling (see
Supplemental Fig. 3A,B). This may in part be attributed to
the effects of noise in the newly transcribed RNA/total RNA
ratios on the logarithmic function used to calculate t1/2.
However, due to their rapid decay, their half-lives can also
be determined with high precision based on preexisting
RNA/total RNA ratios (see Supplemental Methods).
Monitoring interferon-mediated differential
gene expression
Numerous studies on both type I and II IFN-mediated gene
regulation have provided detailed knowledge of their effects
on cellular gene expression (for review, see de Veer et al.
2001). For most IFN-regulated genes changes in transcript
levels only start to become detectable after 2–3 h. Thus,
primary and secondary events are difficult to differentiate.
We applied our method to analyze IFN-mediated gene
regulation in order to show the advantages of this type of
analysis. In a first experiment NIH-3T3 cells were treated
for one hour with either 100 U/mL IFNa, 100 U/mL IFNg,
or F, adding 4sU at the same time. Total cellular RNA was
isolated from cells and newly transcribed RNA was purified.
Three biological replicates of each RNA subset were
subjected to microarray analysis. In a second larger exper-
iment short-term 4sU labeling was performed at different
time intervals during IFN treatment. Specifically, RNA was
labeled during the first 15 and 30 min of IFN receptor
activation and for 30 min starting 30, 90, and 150 min
thereafter. Microarray analyses were performed for three
replicates of newly transcribed RNA labeled from 0 to 30,
30 to 60, and 150 to 180 min and from total RNA following
3 h of IFN treatment. In all experiments the number of
probe sets showing significant (P # 0.05) (more than
fourfold) up-regulation or (less than twofold) down-
regulation was substantially higher for newly transcribed
RNA than for total RNA (Fig. 3A–D). Analysis of newly
transcribed RNA (30–60 min) instead of total RNA (1 h)
increased sensitivity for detection of up- and down-
regulation by more than five- and >10-fold, respectively.
Interestingly, down-regulation during the first 60 min was
exclusively seen after IFNg treatment.
For further analysis microarray data from all experi-
ments were combined including only probe sets >2-fold
regulated and significant (P # 0.01) in any of the 12
statistical comparisons (n = 957, corresponding to 562
unique genes; for a complete list, see Supplemental Table
1). All transcripts which showed significant regulation by
>2-fold during the first hour of IFNa or IFNg treatment
were sorted by their half-life (Fig. 4A–C). The median
mRNA half-life of genes up-regulated by IFNg (t1/2m = 184
min) was significantly shorter than for IFNa (t1/2m = 346
min; P < 0.0001). We observed a strong correlation bet-
ween differential gene expression detectable in total RNA at
1 h and transcript half-life. Similar changes for total RNA
and newly transcribed RNA were only detectable for short-
lived, up-regulated transcripts. In contrast, analysis of
newly transcribed RNA revealed substantial differential
expression independent of transcript half-life, thereby
explaining the superior sensitivity observed when analyzing
newly transcribed RNA.
By quantitative PCR, up-regulation of two major IFN-
induced transcription factors, irf1 (interferon regulatory
factor 1) and socs3 (suppressor of cytokine signaling 3) by
eight- and fivefold, respectively, was already detectable in
newly transcribed RNA after 15 min of IFNg treatment (see
Supplemental Fig. 4). By microarray analysis of newly
transcribed RNA substantial changes in gene expression
were detected after 30 min (data for all conditions
Do¨lken et al.
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visualized in Fig. 4D). Interestingly, virtually all probe sets
(IFNa: 86/86; IFNg 115/119) detecting up-regulation by
more than twofold in newly transcribed RNA after 30 min
also revealed regulation of more than twofold at 30–60
min. Therefore, analysis of newly transcribed RNA produ-
ces highly reliable and reproducible data. Changes in
transcription rates seen already during the first hour were
termed ‘‘primary.’’ This type of regulation peaked in
between 30 and 60 min and mainly remained stable or
started to decline thereafter. For a large part (>25%) of
these transcripts changes remained undetectable in total
RNA at 1 and 3 h. Additional changes seen first at 150–180
min after stimulation were termed ‘‘secondary.’’ These also
accounted for z25% of changes. Interestingly, a large
subset of genes was primary up-regulated by IFNa but
secondary by IFNg. This was remarkable as no induction of
any type I IFN gene was observed during IFNg treatment.
Changes in total RNA after 1 and 3 h of IFN treatment
could be quantitatively explained by corresponding changes
in transcriptional activity when taking into account the
half-life of the corresponding transcripts. No effect of IFN
treatment on RNA stability and decay was observed.
A number of genes have been shown to be down-
regulated after 6 h of IFN treatment. Little is known about
the mechanisms involved (de Veer et al. 2001; Platanias
2005). Interestingly, IFNa did not lead to any substantial
down-regulation of transcription during the first three
hours, indicating that down-regulation observed by others
following longer treatment ($6 h; for
review, see de Veer et al. 2001) is due to
secondary effects. In contrast, we iden-
tified a new subset of very short-lived
transcripts (t1/2m = 90 min) significantly
down-regulated only by IFNg following
30–60 min of treatment. These changes
were almost undetectable in total RNA
at 1 and 3 h when changes seen in newly
transcribed RNA already waned. The
half-lives of down-regulated genes were
much shorter than those of up-regulated
genes (t1/2m = 184 min; P < 10
7).
Based on direct interactions described
for these genes, comprehensive interac-
tion networks were constructed, two of
them showing high connectivity (net-
work scores of 24 and 22, respectively;
see Supplemental Fig. 5A,B). It was
possible to merge these two networks
using direct interactions between nodes
to produce a combined network com-
prising 21 of the 25 ‘‘focus genes’’ used
for network analysis (Fig. 5). The
majority of ‘‘focus genes’’ present
within the networks were located within
the nucleus (16 of 21). Networks
showed associations with control of gene expression,
cellular development, cell death, cellular growth, and pro-
liferation.
DISCUSSION
Here, we report on a novel systemic approach to simulta-
neously analyze short-term changes in RNA synthesis and
decay and their impact on cellular transcript levels. Label-
ing of newly transcribed RNA using 4sU is applicable to a
large variety of cell types and organisms including humans,
mice (Kenzelmann et al. 2007), and plants (Ussuf et al.
1995), as well as Drosophila (data not shown). It can be
used for in vitro and in vivo studies since 4sU is also well
tolerated by mice following i.v. injection (Kenzelmann et al.
2007). It was shown that microarray sensitivity for differ-
ential gene expression can be substantially increased by the
analysis of newly transcribed RNA following two hours of
labeling (Kenzelmann et al. 2007). However, in order to be
able to study the temporal order of transcriptional regula-
tion at molecular level, monitoring at much shorter time
intervals is required. It was shown that incorporation of
4tU can be used to purify newly transcribed RNA from cells
expressing toxoplasma gondii UPRT (Cleary et al. 2005)
following as little as one hour of labeling. However, we
found 4tU incorporation to be dependent on a variety of
factors including cell type and UPRT expression levels (data
not shown), thereby limiting short-term labeling efficiency.
FIGURE 3. Detection of IFN-mediated differential gene expression in newly transcribed RNA
and total RNA. NIH-3T3 cells were treated with 100 U/mL of either IFNa or IFNg or were left
untreated. Newly transcribed RNA was labeled by adding 500 mM 4sU (final concentration)
during 0–30, 0–60, 30–60, and 150–180 min of treatment. Microarray analyses were performed
on three biological replicates of purified newly transcribed RNA (black bars) as well as of total
RNA (empty bars) following 1 and 3 h of treatment. Bar charts depicting the number of probe
sets detecting significant (P # 0.05) >4-fold up-regulation (A,B) or >2-fold down-regulation
(C,D) by either IFNa or IFNg are shown.
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In contrast, incorporation of 4sU into newly transcribed
RNA seems to be predominantly concentration dependent.
Therefore, labeling efficiency can be adjusted according to
the desired duration of labeling and the cell type under
study. We were able to achieve a density of thiolation by
4sU sufficient for in vitro biotinylation and subsequent
efficient separation on magnetic beads following as little as
10 min of labeling.
We studied the response of fibroblasts to type I and II
IFN to test our new approach on a well characterized
template of transcriptional regulation. For the first time, we
were able to determine the temporal
order and kinetics of transcriptional
regulation allowing differentiation of
secondary signaling effects from pri-
mary ones at the time scale of minutes.
In fact, >25% of IFN-induced genes
differentially expressed at 3 h repre-
sented secondary signaling events.
However, two major IFN-induced tran-
scription factors (irf1 and socs3) were
already up-regulated by five- to eight-
fold after 15 min of IFNg treatment,
emphasizing the need to study regulation
of gene expression within this time scale.
Total cellular transcript levels are
constantly subjected to changes in
RNA synthesis and decay. Our method
allows separation of total cellular RNA
into newly transcribed and preexisting
RNA. Thus, RNA synthesis and decay
can be simultaneously analyzed in a
single experimental setting. On the one
hand, analysis of newly transcribed
RNA allows the quantitative study of
regulatory mechanisms governing tran-
scription. This is of particular interest
for subsequent promoter analyses. On
the other hand, removal of newly tran-
scribed RNA from total RNA offers a
simple novel approach to determine
RNA decay rates without having to
block transcription. If steady-state con-
ditions can be assumed, RNA half-life
can even be determined with superior
accuracy based on newly transcribed
RNA/total RNA ratios alone as these
offer a two order of magnitude dynamic
range of measurements instead of the
twofold dynamic range provided for the
majority of transcripts by experiments
using act-D. Thereby, precise data on
RNA decay are obtained even for
medium- to long-lived transcripts. As
no cellular stress response is provoked,
the regulatory mechanisms that govern mRNA decay, like
effects exerted by miRNAs (Bhattacharyya et al. 2006), can
be studied.
Calculating half-lives instead of simply attributing
changes in total RNA to changes in RNA synthesis or
decay as described by Kenzelmann et al. (2007) has several
advantages. First, it allows quantification of the actual
changes in transcript half-life. Changes in transcript half-
life do not simply match changes in newly transcribed
RNA/total RNA ratios. In contrast, depending on how high
the actual half-life is, it may lead to substantially different
FIGURE 4. (Legend on next page)
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results. Second, it allows precise analysis of both changes in
RNA synthesis and decay in case both total and newly
transcribed RNA levels are altered. Third, functional
characteristics can be attributed to genes, e.g., genes with
regulatory function are predominantly represented by
short-lived transcripts. Finally, it makes data from different
experiments comparable.
The most crucial step necessary to be able to compare
data on RNA half-life from independent experiments is
array normalization. Analysis of all three RNA subsets also
provides a new solution to this problem. The standard
approach is to use a housekeeping gene for which a half-life
was independently determined (Frevel et al. 2003; Yang et
al. 2003; Bernstein et al. 2004; Raghavan and Bohjanen
2004). Our approach is based on the concept that total
RNA is quantitatively separated into newly transcribed
RNA and preexisting RNA. Linear regression analysis can
be applied on microarray data of thousands of transcripts.
Therefore, array normalization is not dependent on the
precision of the measurements of single transcripts any
more but can now be based on thousands of probe sets of
the actual microarray data under study.
By comparing the regulatory changes detectable for
total RNA and newly transcribed RNA after 1 h of IFN
treatment with transcript half-life, we show that the low
temporal resolution of standard microarray analysis is due
to the relatively long half-life of mammalian mRNAs. Thus,
standard microarray analyses carried out on total RNA
have a bias for picking up changes for short-lived tran-
scripts. These predominantly represent regulatory genes
and transcription factors creating further bias in sub-
sequent analysis (Raghavan et al. 2002). With our approach
even a transient regulation can now be revealed indepen-
dent of transcript half-life. We clearly show that changes in
gene expression occurring during the first hour following a
stimulus are independent of transcript half-life.
Our approach is particularly well suited to detect
transient down-regulation in transcription rates which is
often impossible to pick up by measuring transcript
abundance only. Thus, we found a new subset of short-
lived genes selectively down-regulated following 30–60 min
of IFNg treatment, which was not detectable in conven-
tional total RNA at 1 and 3 h. We show that these genes
form a high connectivity functional network affecting cell
cycle and apoptosis, suggesting that this response is a
relevant part of IFNg signaling. Interestingly, this response
was only detectable in the second 30 min of IFN treatment.
Therefore, it represents an early but potentially already
secondary response specific to interferon g.
In summary, by combining short-term analysis of RNA
synthesis with simultaneous measurements of RNA decay, a
comprehensive picture of the regulatory mechanism gov-
erning gene expression can be obtained.
MATERIALS AND METHODS
Cell culture and metabolic labeling of cellular RNA
Murine NIH-3T3 fibroblasts (ATCC CRL1658) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 5% newborn calf serum (NCS). Human and murine cell
lines including human epithelial cells (HeLa), T-cells (Jurkat), and
B-cells (BL41 & DG75), as well as murine macrophages (RAW
264.7) and endothelial cells (SVEC 4-10) were cultured according
to ATCC standards. For metabolic labeling of RNA in NIH-3T3
cells 4-thiouridine (Sigma) was added to a 200 mM final concen-
tration into prewarmed, CO2-equilibrated medium in all 60-min
labeling experiments (cells used only in between 5. and 15. passage
after thawing; split twice weekly and 24 h before start of labeling).
For short-term labeling (#30 min), 500 mM 4sU was used. For
most cell types growing in suspension (human B- and T-cells
and murine macrophages) 100 mM 4sU was found to be optimal
for 60-min labeling experiments (data not shown). Total cellular
RNA was isolated from cells using Trizol
reagent (Invitrogen) following the modified
protocol described by Chomczynski and
Mackey (1995).
For combined 4sU and radioactive RNA
labeling 5 mM (60-min labeling with 200 mM
4sU) or 12.5 mM (15- and 30-min labeling
with 500 mM 4sU) 5-3H-cytidine (25 Ci/
mmol, Sigma) was added to the culture media
together with the 4sU. For these experiments
RNA was extracted using RNeasy kit (Qiagen)
to remove unincorporated 5-3H-cytidine.
In order to determine mRNA decay rates
by blocking transcription, act-D (Sigma) was
used at a final concentration of 5 mg/mL.
Both murine IFNa (IFN-aA, PBL Biomed-
ical Laboratories) and murine IFNg (Chem-
icon) were used at a final concentration of
100 U/mL in all experiments. In every
experiment IFN activity was controlled using
FIGURE 4. Monitoring IFNa- and IFNg-mediated differential gene expression. Represented
are all genes which were found to be significantly regulated (P # 0.01) within any condition
during the first 60 min of IFN treatment (A–C) or in any of the 12 statistical comparisons (D).
Each row represents a gene, each column a biological condition. Red-to-black represents up-
regulation with respect to mock-treated samples, white represents no change, and blue
represents down-regulation. (A–C) Correlation of detectable differential gene expression with
mRNA half-life. Heat-maps including genes (A) up-regulated by IFNa, (B) up-regulated by
IFNy, and (C) down-regulated by IFNg by twofold for which half-life could be calculated
based on newly transcribed RNA/total RNA ratios are shown. Genes were sorted according to
their half-life (top to bottom). Gray scales depicted on the left indicate the half-life of the
corresponding group of transcripts ranging from <2 to >16 h. Changes in transcript levels
detectable in total RNA after 1 h of IFNa or IFNg treatment strongly depend on the half-life of
the corresponding transcript. In contrast, analysis of newly transcribed RNA revealed
substantial differential expression independent of transcript half-life. (D) Temporal order
and kinetics of IFNa- and IFNg-mediated gene regulation. Genes were sorted by similarity
(hierarchical clustering) of their regulation across four of the 12 conditions: newly transcribed
RNA from 30–60 min (primary) and 150–180 min (secondary) for IFNa and IFNg. Changes in
transcription rates seen already during the first hour were termed ‘‘primary’’ (1°). Additional
changes seen first at 150–180 min after stimulation were termed ‘‘secondary’’ (2°). ‘‘*’’
indicates transcripts down-regulated only during the first hour of IFNg treatment with down-
regulation not detectable in total RNA at 1 and 3 h at all.
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the ISRE Luc reporter cell line, which expresses luciferase under an
IFN inducible promoter (Zimmermann et al. 2005; data not shown).
Biotinylation and purification of 4sU-labeled RNA
Biotinylation of 4sU-labeled RNA was performed using EZ-Link
Biotin-HPDP (Pierce) dissolved in dimethylformamide (DMF) at
a concentration of 1 mg/mL and stored at 4°C. Biotinylation was
carried out in 10 mM Tris (pH 7.4), 1 mM EDTA, and 0.2 mg/mL
Biotin-HPDP at a final RNA concentration of 100 ng/mL for 1.5 h
at room temperature. In general 50–100 mg total RNA were used
for the biotinylation reaction. By dot blot assay (see below)
we noted that simple precipitation of biotinylated RNA using
isopropanol/ethanol as described (Cleary et al. 2005) leads to
coprecipitation of large amounts of unbound biotin. As this
is likely to interfere with capture of biotinylated RNA by
streptavidin-coated magnetic beads we efficiently removed
unbound Biotin-HPDP by chloroform/isoamylalcohol (24:1)
extraction using Phase-lock-gel (Heavy) tubes (Eppendorf). After-
ward, a 1/10 volume of 5 M NaCl and an equal volume of
isopropanol were added and RNA was precipitated at 20,000g for
20 min. The pellet was washed with an equal volume of 75%
ethanol and precipitated again at 20,000g for 10 min. The pellet
was resuspended in 50–100 mL RNAse-free water. After denatur-
ation of RNA samples at 65°C for 10 min followed by rapid
cooling on ice for 5 min, biotinylated RNA was captured using
mMACS streptavidin beads and columns (Miltenyi). Our column-
based assay eliminated the risk of carry-over of unlabeled RNA we
observed when using the original protocol (Cleary et al. 2005). Up
to 100 mg of biotinylated RNA were incubated with 100 mL of
mMACS streptavidin beads with rotation for 15 min at room
temperature. The beads were transferred and magnetically fixed to
the columns. Columns were washed three times with 1 mL 65°C
washing buffer (100 mM Tris-HCl, pH 7.4, 10 mM EDTA, 1 M
NaCl, 0.1% Tween20) followed by three washes with room
temperature washing buffer. To recover the unlabeled preexisting
RNA the flow-through of the first two washes was collected and
combined. Labeled RNA was eluted by the addition of 100 mL of
freshly prepared 100 mM dithiothreitol (DTT) followed by a
second elution round 5 min later. RNA was recovered from the
washing fractions and eluates using the RNeasy MinElute Spin
columns (Qiagen).
Detection of 4sU incorporation by dot blot assay
Dot blot analysis on biotinylated RNA samples was carried out
to detect and quantify the amount of RNA-bound biotin residues
within a given RNA sample. First, biotinylated RNA samples
were denaturated for 10 min at 65°C and subsequently placed on
ice for 5 min. RNA samples were diluted in ice-cold alkaline
binding buffer (10 mM NaOH, 1 mM EDTA) at a concentration
of 1 mg/200 mL and spotted onto a Zeta+-probe blotting
membrane (Bio-Rad) in 10-fold dilutions (1 mg down to 1 ng)
using the Bio-Dot Apparatus (Bio-Rad). A 59-biotinylated DNA
oligo of 81 nt was used as quantitative positive control and
applied to the membrane in 10-fold dilutions (100 ng down to 0.1
ng). After rinsing each well with 500 mL alkaline binding
buffer, the blotting apparatus was disassembled and the mem-
brane was incubated in blocking solution (phosphate buffered
saline [PBS], pH 7.5, 10% SDS, 1 mM EDTA) for 20 min. The
membrane was probed with 1:1000 dilution of 1 mg/mL strepta-
vidin-horseradish peroxidase (Pierce) in blocking solution for 15
min. The membrane was washed six times in PBS containing
decreasing concentrations of SDS (10%, 1%, and 0.1% SDS,
applied twice each) for 10 min. The signal of biotin-bound
horseradish peroxidase was visualized by ECL detection reagent
(Amersham).
Reverse transcription and real-time PCR
Reverse transcription of 100 ng purified newly transcribed RNA
was carried out in 25 mL reactions using Superscript III (Invi-
trogen) and oligo-dT primers (Invitrogen) following the manu-
facturers instructions. PCR was performed on a Light Cycler
(Roche Molecular Biochemicals). Each reaction was carried out
using 5 mL of cDNA (1:10 dilution) and 15 mL reaction mixtures
of Light Cycler Fast Start, DNA MasterPlus Sybr Green I and 0.5
mM of the primers. PCRs were subjected to 10 min of 95°C hot-
start, and Sybr Green incorporation was monitored for 45 cycles
of 95°C denaturation for 10 sec, 58°C annealing for 3 sec, and
72°C elongation for 10 sec, followed by melting curve analysis to
confirm specific amplification. The specific primer pairs for each
target are listed in Supplemental Table 2. Standard curves were
prepared using cDNA prepared from total RNA of NIH-3T3
cells. Relative quantification was performed based on gapdh
normalization.
Microarray sample labeling, hybridization,
and preprocessing
Total RNA (1.5 mg) and newly transcribed RNA (280 ng) were
amplified and labeled using the Affymetrix One-Cycle Target
Labeling Kit according to the manufacturer’s recommendations.
As newly transcribed RNA mainly consists of mRNA, it was
amplified and labeled according to the manufacturer’s protocol
for mRNA. The amplified and fragmented biotinylated cRNA was
hybridized to Affymetrix MG 430 2.0 arrays using standard
procedures.
Microarray data processing and statistical analysis
for analysis of IFN-mediated gene regulation
Data were processed and analyzed with R and Bioconductor
(Gentleman et al. 2004; R Development Core Team 2007). For the
analysis of IFN-mediated differential gene expression processing
and statistical hypothesis testing was implemented separately for
total RNA and newly transcribed RNA data sets. The former
contains a total of 24 arrays in seven biological conditions, the
latter 36 arrays in 12 biological conditions (for details, see
Supplemental Table 3).
Arrays were assessed for quality, GCRMA-normalized, filtered
for low and invariant expression, and analyzed using an empirical
Bayes moderated t-test for paired samples. Hybridization results
for newly transcribed RNA and total RNA were expected and
observed to show significant differences.
‘‘Quality assessment’’ consisted of RNA degradation plots,
Affymetrix quality control metrics, sample cross-correlation, data
distributions, and probe-level visualizations.
‘‘Normalization’’ incorporated (separately for each RNA type
data set) background correction, normalization, and probe-level
summation by GCRMA.
Do¨lken et al.
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‘‘Nonspecific filters’’ consisted of a combined intensity-based
and variation-based step removing genes that can safely be con-
sidered to be biologically irrelevant or nonmeasurable by micro-
array technology. Filter one only retains genes which are called
‘‘present’’ or ‘‘marginal’’ in at least three out of the total number
of arrays in that data set. Filter two only retains genes with a
measured Inter-Quartile-Range $0.75. In the total RNA data set,
n = 4327 genes pass this combined filter; in the newly transcribed
RNA data set, this number is n = 10,053. The difference in
numbers is due to the higher proportion of ‘‘present’’ probes in
the newly transcribed RNA data set.
‘‘Statistical testing’’ for differential expression was applied
separately for the total RNA and newly transcribed RNA data
sets. Analysis hypotheses were centered around the effect of IFNa
and IFNg at particular time points, compared to mock-treated
samples. The small statistical sample size for individual biological
conditions is partly offset by the paired nature of samples, in that
the mock and treatment samples are the same sample with the
only difference being the treatment received. This is made use of
by applying a paired-test version of the empirical Bayes moderated
t-test (Smyth 2004), which in itself is the most robust test for
small sample sizes. An increased rate of false-positive results due
to simultaneously testing on a large number of genes was
corrected for by applying a multiple testing correction algorithm
to the observed P-values, in this case using the Benjamini and
Hochberg method (Benjamini and Hochberg 1995). Fisher’s exact
test was applied for comparison of the number of down-regulated
genes in between IFNa and IFNg for newly transcribed RNA.
Calculation of mRNA half-life based on newly
transcribed/total RNA ratios, preexisting RNA/total
RNA ratios, and actinomycin-D data
The different bioinformatical approaches used to determine RNA
half-lives are described in detail in the Supplemental Methods. For
all experiments three biological replicates of each RNA subset were
subjected to microarray analysis.
In total this comprised 45 arrays in 11 biological conditions (for
details, see Supplemental Table 3).
To calculate RNA half-lives CEL-files of all samples from all
conditions (including total RNA, newly transcribed RNA, and
preexisting RNA as well as the act-D RNA samples) were
normalized together using the GCRMA algorithm (R Develop-
ment Core Team 2007). Only probe sets called ‘‘present’’ in all
three replicates of all three RNA subsets under study were
included in the analysis of transcript half-lives. Statistical com-
parison of half-life values between groups was performed using
the Wilcoxon rank–sum test.
Pathway analysis for genes down-regulated by IFNg
Network analysis involved upload of gene identifier lists to the
ingenuity pathway analysis (IPA) software application. The IPA
Knowledge Base, a comprehensive knowledge base of biological
findings for genes of human, mouse, and rat, was used to
construct pathways and functional modules. The IPA application
maps each gene identifier to its corresponding gene object in the
IPA Knowledge Base. These focus genes are then overlaid onto a
global molecular network developed from information contained
in the Knowledge Base. Networks of focus genes are then
algorithmically generated based on their connectivity and assigned
a significance score (based on P-values) representing the likeli-
hood that the focus genes within the network are found there by
chance. A high number of focus genes within a data set leads to a
higher network score (equal to the negative exponent of the
respective P-value). To identify focus genes down-regulated after
IFNg treatment, the database was queried using the 44 probe IDs
present in this list and 25 focus genes were identified as eligible for
network analysis. Comprehensive interaction networks were con-
structed showing high connectivity (Network 1 score of 24 and
Network 2 score of 22; for details, see Supplemental Fig. 5A,B).
SUPPLEMENTAL DATA
Supplemental material can be found at http://www.rnajournal.org.
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